ORMALVI
NDC 70709-085, Dichlorphenamide, tablet, from Cycle Pharmaceuticals Ltd..
- Product NDC
- 70709-085
- Status
- Listed
- Labeler
- Cycle Pharmaceuticals Ltd.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215924
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70709-085 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DICHLORPHENAMIDE50 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70709-085-10 | 70709008510 | 100 TABLET in 1 BOTTLE (70709-085-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3989e220-6502-449b-be39-e2689acce08c
Use it
Look up 70709-085 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70709-085 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70709-085. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.